Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$40.64 USD
+0.49 (1.22%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $40.54 -0.10 (-0.25%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
Tandem Diabetes Care, Inc. [TNDM]
Reports for Purchase
Showing records 141 - 160 ( 240 total )
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Diabetes: Artificial Pancreas Workshop Provides Insights On the Future of the Diabetes Market
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
American Diabetes Association Meeting Suggests a Diabetes Technology Renaissance Is Coming; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
J-J Medical Devices Investor Day Takeaways on Robotic Surgery, Diabetes, AFib,Sinus Surgery, Endoscopic Stapling
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Volatility in Diabetes Stocks Following UNH/MDT Agreement Creates Buying Opportunity; Reiterate OUTPERFORM on DXCM, PODD, TNDM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Strong performance continues as Q1 beats, guidance raised, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Demand For Tandem''s Insulin Pumps Exceeds Expectations; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Feltl Insulin Pump Project: Historical survey of ~6,000 users
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 1Q16 Results
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
1Q16 MedTech Preview: Stable Trends; Prefer the Oversold Names With Solid Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Slim with G4 CGM and pipeline bring momentum into 2016, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Q4 2015 Insulin Pump Project: Historical survey of -6,000 users
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Guidance and Margins Much Better Than Expected, Paving a Path Toward Profitability; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Survey of Diabetes Educators Very Positive for DXCM''s Growth Outlook; Suggests Recent Concerns Misplaced; Reiterate OUTPERFORM on DXCM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Suggests Patients Prefer Tandem''s Insulin Pumps; Reiterate OUTPERFORM on TNDM shares
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Pre-Announces In Line 4Q15 And Initial 2016 Revenue Guidance; Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.